Microdialysis monitoring of glucose, lactate, glycerol, and pyruvate in patients with diabetic ketoacidosis

International Journal of Artificial Organs

Volumn 36, Issue 12, 2013, Pages 869-877

  Ciechanowska, Anna ^a   Ladyzynski, Piotr ^a   Wojcicki, Jan M ^a   Sabalinska, Stanislawa ^a   Krzymien, Janusz ^b   Pulawska, Elzbieta ^b   Karnafel, Waldemar ^b   Foltynski, Piotr ^a   Kawiak, Jerzy ^a  

^a INSTITUTE OF BIOCYBERNETICS AND BIOMEDICAL ENGINEERING   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Diabetes mellitus; Diabetic ketoacidosis; Microdialysis

Indexed keywords

BLOOD; BLOOD VESSELS; DIALYSIS; GLYCEROL; KETONES; METABOLISM; METABOLITES;

ADIPOSE TISSUE; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; GLUCOSE CONCENTRATION; INTERSTITIAL FLUIDS; MICRO-DIALYSIS; PYRUVATES; RECOVERY COEFFICIENTS; TYPE 1 DIABETES; TYPE-2 DIABETES;

GLUCOSE;

GLUCOSE; GLYCEROL; LACTIC ACID; PYRUVIC ACID;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIABETIC KETOACIDOSIS; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTERSTITIAL FLUID; MALE; MEDICAL DEVICE; MICRODIALYSIS; MICRODIALYSIS PROBE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT MONITORING;

ADIPOSE TISSUE; ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC KETOACIDOSIS; EXTRACELLULAR FLUID; FEMALE; GLYCEROL; HUMANS; LACTIC ACID; MALE; MICRODIALYSIS; MIDDLE AGED; PYRUVIC ACID; TIME FACTORS; YOUNG ADULT;

EID: 84891084970     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.5301/ijao.5000265     Document Type: Article

References (44)

1. English P, Williams G. Hyperglycaemic crises and lactic aci-dosis in diabetes mellitus. Postgrad Med J. 2004;80(943): 253-261.
2. Kitabchi AE, Umpierrez GE, Murphy MB, et al. Management of hyperglycemic crises in patients with diabetes. Diabetes Care. 2001;24(1):131-153.
3. Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hypergly-cemic crises in adult patients with diabetes. Diabetes Care. 2009;32(7):1335-1343.
4. Kitabchi AE, Umpierrez GE, Fisher JN, Murphy MB, Stentz FB. Thirty years of personal experience in hyper-glycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state. J Clin Endocrinol Metab. 2008;93(5): 1541-1552.
5. Mazer M, Chen E. Is subcutaneous administration of rapid-acting insulin as effective as intravenous insulin for treating diabetic ketoacidosis? Ann Emerg Med. 2009;53(2):259-263.
6. Chiasson JL, Aris-Jilwan N, Bélanger R, et al. Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state. CMAJ. 2003;168(7):859-866.
7. Henriksen OM, Prahl JB, Røder ME, Svendsen OL. Treatment of diabetic ketoacidosis in adults in Denmark: a national survey. Diabetes Res Clin Pract. 2007;77(1):113-119.
8. Li Y, Peris J, Zhong L, Derendorf H. Microdialysis as a tool in local pharmacodynamics. AAPS J. 2006;8(2):E222-235.
9. Müller M. Science, medicine, and the future: Microdialysis. BMJ. 2002;324(7337):588-591.
10. Ungerstedt U. Microdialysis - principles and applications for studies in animals and man. J Intern Med. 1991;230(4): 365-373.
11. Ciechanowska A, Sabalinska S, Gutowska M, et al. Modern application of membrane technique in therapeutic and diagnostic medical systems. Biocybern Biomed Eng. 2008;28(2):21-33.
12. Schoonen AJ, Wientjes KJ. A model for transport of glucose in adipose tissue to a microdialysis probe. Diabetes Technol Ther. 2003;5(4):589-598.
13. Ciechanowska A, Wojcicki JM, Maruniak-Chudek I, et al. Microdialysis as a monitoring system for human diabetes. In: T-H. Tsai, ed. Applications of Microdialysis in Pharmaceutical Science. Hoboken, New Jersey: John Wiley & Sons; 2011:359-402.
14. Hagström-Toft E, Bolinder J, Ungerstedt U, Arner P. A cir-cadian rhythm in lipid mobilization which is altered in IDDM. Diabetologia. 1997;40(9):1070-1078.
15. Rajamand N, Ungerstedt U, Brismar K. Subcutaneous mi-crodialysis before and after an oral glucose tolerance test: a method to determine insulin resistance in the subcutaneous adipose tissue in diabetes mellitus. Diabetes Obes Metab. 2005;7(5):525-535.
16. Kapitza Ch, Hövelmann U, Nosek L, et al. Continuous Glucose Monitoring during Exercise in Patients with Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion. J Diabetes Sci Technol. 2010;4(1):123-131.
17. Szabó Z, Andersson RGG, Arnqvist HJ. Intraoperative muscle and fat metabolism in diabetic patients during coronary artery bypass grafting surgery: a parallel microdialysis and organ balance study. Br J Anaesth. 2009;103(2):166-172.
18. Stolle LB, Riegels-Nielsen P. The metabolism of the diabetic foot: in vivo investigation with microdialysis. Acta Orthop Scand. 2004;75(1):106-108.
19. Mader JK, Feichtner F, Bock G, et al. Microdialysis - a versatile technology to perform metabolic monitoring in diabetes and critically ill patients. Diabetes Res Clin Pract. 2012;97(1):112-118.
20. Ciechanowska A, Ladyzynski P, Wojcicki JM, et al. Microdi-alysis technique as a monitoring system for acute complications of diabetes. Artif Organs. 2008;32(1):45-51.
21. Wojcicki JM, Ciechanowska A, Sabalinska S, et al. Micro-dialysis technique in monitoring of the patient's metabolic state. Biocybern Biomed Eng. 2007;27(1/2):53-64.
22. Wientjes KJ, Vonk P, Vonk-van Klei Y, Schoonen AJ, Kos-sen NW. Microdialysis of glucose in subcutaneous adipose tissue up to 3 weeks in healthy volunteers. Diabetes Care. 1998;21(9):1481-1488.
23. Monsod T P, Flanagan DE, Rife F, et al. Do sensor glucose levels accurately predict plasma glucose concentrations during hypoglycemia and hyperinsulinemia? Diabetes Care. 2002;25(5):889-893.
24. Bolinder J, Ungerstedt U, Arner P. Long-term continuous glucose monitoring with microdialysis in ambulatory insulin-dependent diabetic patients. Lancet. 1993;342(8879): 1080-1085.
25. Rosdahl H, Hamrin K, Ungerstedt U, Henriksson J. Metabolite levels in human skeletal muscle and adipose tissue studied with microdialysis at low perfusion flow. Am J Physiol Endocrinol Metab. 1998;274(5 Pt 1):E936-945.
26. Rajamand N, Ungerstedt U, Brismar K. Subcutaneous mi-crodialysis before and after an oral glucose tolerance test: a method to determine insulin resistance in the subcutaneous adipose tissue in diabetes mellitus. Diabetes Obes Metab. 2005;7(5):525-535.
27. Petriczko E, Horodnicka-Jozwa A, Grabowska-Wnuk W, Sienko M, Syrenicz A, Walczak M. Interstitial measurements of glucose, glycerol and lactate in adolescents with decompensated type 1 diabetes. Neuro Endocrinol Lett. 2010;31(4):559-567.
28. Qvisth V, Hagström-Toft E, Moberg E, Sjöberg S, Bolinder J. Lactate release from adipose tissue and skeletal muscle in vivo: defective insulin regulation in insulin-resistant obese women. Am J Physiol Endocrinol Metab. 2007;292(3):E709-714.
29. Samuvel DJ, Sundararaj K P, Nareika A, Lopes-Virella MF, Huang Y. Lactate boosts TLR4 signaling and NF-kappaB pathway-mediated gene transcription in macrophages via monocarboxylate transporters and MD-2 up-regulation. J Immunol. 2009;182(4):2476-2484.
30. Sandqvist MM, Eriksson JW, Jansson PA. Increased lactate release per fat cell in normoglycemic first-degree relatives of individuals with type 2 diabetes. Diabetes. 2001;50(10): 2344-2348.
31. Rosenthal MD, Glew RH. Medical Biochemistry: Human Metabolism in Health and Disease. Hoboken, NJ: John Wiley & Sons; 2009.
32. Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science. 2005;307(5708):384-387.
33. Patti ME, Corvera S. The role of mitochondria in the patho-genesis of type 2 diabetes. Endocr Rev. 2010;31(3):364-395.
34. Sivitz W. Mitochondrial dysfunction in obesity and diabetes. US Endocrinology. 2010;6(1):20-27.
35. Jitrapakdee S, Wutthisathapornchai A, Wallace JC, MacDonald MJ. Regulation of insulin secretion: role of mito-chondrial signalling. Diabetologia. 2010;53(6):1019-1032.
36. Marshall WJ, Bangert SK. Clinical biochemistry: metabolic and clinical aspects. Amsterdam: Elsevier Limited; 2008:302.
37. Crawford SO, Hoogeveen RC, Brancati FL, et al. Association of blood lactate with type 2 diabetes: the Atherosclerosis Risk in Communities Carotid MRI Study. Int J Epidemiol. 2010;39(6):1647-1655.
38. Nurjhan N, Consoli A, Gerich J. Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus. J Clin Invest. 1992;89(1): 169-175.
39. DeFronzo RA. Overview of newer agents: where treatment is going. Am J Med. 2010;123(3):S38-48.
40. Groop LC, Saloranta C, Shank M, Bonadonna RC, Ferrannini E, DeFronzo RA. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and nonin-sulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1991;72(1):96-107.
41. Belfort R, Mandarino L, Kashyap S, et al. Dose-response effect of elevated plasma free fatty acid on insulin signaling. Diabetes. 2005;54(6):1640-1648.
42. Vergès B. Abnormal hepatic apolipoprotein B metabolism in type 2 diabetes. Atherosclerosis. 2010;211(2):353-360.
43. Hagström-Toft E, Enoksson S, Moberg E, Bolinder J, Arner P. Absolute concentrations of glycerol and lactate in human skeletal muscle, adipose tissue, and blood. Am J Physiol. 1997;273(3 Pt 1):E584-592.
44. Aimaretti G, Corneli G, Razzore P, et al. Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults. J Clin Endocrinol Metab. 1998;83(5):1615-1618.